Access the full text.
Sign up today, get DeepDyve free for 14 days.
G. Bradshaw, T. Capaldo, Lorin Lindner, C. Jung, S. Freud, St Loyola, S. Francis, D. Bjorklund, M. Brüne, U. Brüne-Cohrs, P. Jones, D. Durham, O. Mein-Gans, P. Mudd, J. Borchers, H. Krystal, N. Megna, V. Muller-Paisner, M. Watkins, C. Wiser, D. Bell, P. Ragan, Bradshaw
Developmental Context Effects on Bicultural Posttrauma Self Repair in Chimpanzees Gloria Grow Fauna Foundation
V. Brass, D. Moradpour, H. Blum (2007)
Hepatitis C virus infection: in vivo and in vitro modelsJournal of Viral Hepatitis, 14
J. McHutchison, B. Bacon, S. Gordon, E. Lawitz, M. Shiffman, N. Afdhal, I. Jacobson, A. Muir, M. Al-Adhami, M. Morris, J. Lekstrom-Himes, S. Efler, H. Davis (2007)
Phase 1B, randomized, double‐blind, dose‐escalation trial of CPG 10101 in patients with chronic hepatitis C virusHepatology, 46
P. Simmonds (2004)
Genetic diversity and evolution of hepatitis C virus--15 years on.The Journal of general virology, 85 Pt 11
Q. Choo, G. Kuo, R. Ralston, A. Weiner, D. Chien, G. Nest, Jang Han, K. Berger, K. Thudium, C. Kuo (1994)
Vaccination of chimpanzees against infection by the hepatitis C virus.Proceedings of the National Academy of Sciences of the United States of America, 91
A. Prince, B. Brotman, Dong‐Hun Lee, W. Pfahler, N. Tricoche, L. Andrus, M. Shata (2005)
Protection against chronic hepatitis C virus infection after rechallenge with homologous, but not heterologous, genotypes in a chimpanzee model.The Journal of infectious diseases, 192 10
Kai Lin, R. Perni, A. Kwong, Chao Lin (2006)
VX-950, a Novel Hepatitis C Virus (HCV) NS3-4A Protease Inhibitor, Exhibits Potent Antiviral Activities in HCV Replicon CellsAntimicrobial Agents and Chemotherapy, 50
Tom Baldwin, M. Brazier (2005)
The ethics of research involving animals
P. Farci (2002)
Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome [Science 1989;244:359-362].Journal of hepatology, 36 5
Seung Lee, Jae-Ho Cho, Y. Sung (1998)
Optimal Induction of Hepatitis C Virus Envelope-Specific Immunity by Bicistronic Plasmid DNA Inoculation with the Granulocyte-Macrophage Colony-Stimulating Factor GeneJournal of Virology, 72
Suzanne Bassett, K. Brasky, R. Lanford (1998)
Analysis of Hepatitis C Virus-Inoculated Chimpanzees Reveals Unexpected Clinical ProfilesJournal of Virology, 72
P. Pancholi, Q. Liu, N. Tricoche, P. Zhang, M. Perkus, A. Prince (2000)
DNA prime-canarypox boost with polycistronic hepatitis C virus (HCV) genes generates potent immune responses to HCV structural and nonstructural proteins.The Journal of infectious diseases, 182 1
Hong Yu, L. Babiuk, S. Hurk (2004)
Priming with CpG-enriched plasmid and boosting with protein formulated with CpG oligodeoxynucleotides and Quil A induces strong cellular and humoral immune responses to hepatitis C virus NS3.The Journal of general virology, 85 Pt 6
R. Thimme, D. Oldach, Kyong‐Mi Chang, C. Steiger, S. Ray, F. Chisari (2001)
Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus InfectionThe Journal of Experimental Medicine, 194
E. Ilan, R. Eren, I. Lubin, O. Nussbaum, Arie Zauberman, S. Dagan (2002)
The Trimera mouse: a system for generating human monoclonal antibodies and modeling human diseases.Current opinion in molecular therapeutics, 4 2
(2009)
New Frontiers in Therapy Clinical Symposium: New Direct Acting Antivirals (DAAs) in Development for HCV Infection. Bethesda, MD, USA: Digestive Disease Week
H. Rosen, P. Martín (2000)
Hepatitis B and C in the liver transplant recipient.Seminars in liver disease, 20 4
G. Duverlie, C. Wychowski (2007)
Cell culture systems for the hepatitis C virus.World journal of gastroenterology, 13 17
N. Kneteman, A. Weiner, J. O’Connell, M. Collett, Tiejun Gao, L. Aukerman, Rosemary Kovelsky, Z. Ni, Ahmad Hashash, Janine Kline, B. Hsi, D. Schiller, D. Douglas, D. Tyrrell, D. Mercer (2006)
Anti‐HCV therapies in chimeric scid‐Alb/uPA mice parallel outcomes in human clinical applicationHepatology, 43
J. Youn, Su‐Hyung Park, Jae-Ho Cho, Y. Sung (2003)
Optimal Induction of T-Cell Responses against Hepatitis C Virus E2 by Antigen Engineering in DNA ImmunizationJournal of Virology, 77
M. Colombo, Q. Choo, E. Ninno, N. Dioguardi, G. Kuo, M. Donato, M. Tommasini, M. Houghton (1989)
PREVALENCE OF ANTIBODIES TO HEPATITIS C VIRUS IN ITALIAN PATIENTS WITH HEPATOCELLULAR CARCINOMAThe Lancet, 334
A. Takaki, M. Wiese, G. Maertens, E. Depla, U. Seifert, A. Liebetrau, Jeffery Miller, M. Manns, B. Rehermann (2000)
Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis CNature Medicine, 6
H. Wedemeyer, Xiaosong He, M. Nascimbeni, A. Davis, H. Greenberg, J. Hoofnagle, T. Liang, H. Alter, B. Rehermann (2002)
Impaired Effector Function of Hepatitis C Virus-Specific CD8+ T Cells in Chronic Hepatitis C Virus Infection1The Journal of Immunology, 169
Y. Horsmans, T. Berg, J. Desager, T. Mueller, E. Schott, S. Fletcher, K. Steffy, L. Bauman, B. Kerr, D. Averett (2005)
Isatoribine, an agonist of TLR7, reduces plasma virus concentration in chronic hepatitis C infectionHepatology, 42
A. Vecchio, R. Sarisky (2006)
Small molecule and biologic inhibitors of hepatitis C virus: a symbiotic approach.Mini reviews in medicinal chemistry, 6 11
M. Yu, B. Bartosch, Pei Zhang, Zheng-ping Guo, P. Renzi, Li-ming Shen, Christelle Granier, S. Feinstone, F. Cosset, R. Purcell (2004)
Neutralizing antibodies to hepatitis C virus (HCV) in immune globulins derived from anti-HCV-positive plasma.Proceedings of the National Academy of Sciences of the United States of America, 101 20
J. Gottwein, J. Bukh (2008)
Cutting the gordian knot-development and biological relevance of hepatitis C virus cell culture systems.Advances in virus research, 71
R. Lanford, E. Hildebrandt-Eriksen, A. Petri, R. Persson, M. Lindow, M. Munk, S. Kauppinen, H. Ørum (2010)
Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus InfectionScience, 327
クレットン‐スコット エリカ, グプタ クスム, ヘルナンデズ‐サントイアゴ ブレンダ, ラルスソン マリタ (2009)
Compounds and pharmaceutical compositions for the treatment of viral infections
N. Kato, M. Hijikata, Y. Ootsuyama, M. Nakagawa, S. Ohkoshi, Takashi Sugimura, K. Shimotohno (1990)
Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis.Proceedings of the National Academy of Sciences of the United States of America, 87 24
R. Bartenschlager (2006)
Hepatitis C virus molecular clones: from cDNA to infectious virus particles in cell culture.Current opinion in microbiology, 9 4
G. Kalkeri, N. Khalap, S. Akhter, R. Garry, C. Fermin, S. Dash (2001)
Hepatitis C viral proteins affect cell viability and membrane permeability.Experimental and molecular pathology, 71 3
Catherine Bigger, B. Guerra, K. Brasky, G. Hubbard, M. Beard, B. Luxon, S. Lemon, R. Lanford (2004)
Intrahepatic Gene Expression during Chronic Hepatitis C Virus Infection in ChimpanzeesJournal of Virology, 78
Q. Choo, G. Kuo, A. Weiner, L. Overby, D. Bradley, M. Houghton (1989)
Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.Science, 244 4902
N. Sakamoto, Mamoru Watanabe (2009)
New therapeutic approaches to hepatitis C virusJournal of Gastroenterology, 44
A. Knight (2007)
The Poor Contribution of Chimpanzee Experiments to Biomedical ProgressJournal of Applied Animal Welfare Science, 10
C. Rollier, G. Paranhos-Baccalà, E. Verschoor, B. Verstrepen, J. Drexhage, Z. Fagrouch, J. Berland, F. Komurian-Pradel, Blandine Duverger, Nourrédine Himoudi, C. Staib, Marcus Meyr, M. Whelan, J. Whelan, Victoria Adams, E. Larrea, J. Riezu, J. Lasarte, B. Bartosch, F. Cosset, W. Spaan, H. Diepolder, G. Pape, G. Sutter, G. Inchauspe, J. Heeney (2007)
Vaccine‐induced early control of hepatitis C virus infection in chimpanzees fails to impact on hepatic PD‐1 and chronicityHepatology, 45
K. Moriya, H. Fujie, Y. Shintani, H. Yotsuyanagi, T. Tsutsumi, K. Ishibashi, Y. Matsuura, S. Kimura, T. Miyamura, K. Koike (1998)
The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic miceNature Medicine, 4
Y. Falck-Ytter, H. Kale, K. Mullen, S. Sarbah, Lucian Sorescu, A. McCullough (2002)
Surprisingly Small Effect of Antiviral Treatment in Patients with Hepatitis CAnnals of Internal Medicine, 136
R. Lanford, B. Guerra, Helen Lee, D. Chavez, K. Brasky, Catherine Bigger (2006)
Genomic response to interferon‐α in chimpanzees: Implications of rapid downregulation for hepatitis C kineticsHepatology, 43
M. Martinot‐Peignoux, N. Boyer, D. Cazals‐Hatem, B. Pham, A. Gervais, V. Breton, S. Lévy, C. Degott, D. Valla, P. Marcellin (2001)
Prospective study on anti‐hepatitis C virus–positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNAHepatology, 34
R. Lanford, D. Chavez, L. Notvall, K. Brasky (2003)
Comparison of tamarins and marmosets as hosts for GBV-B infections and the effect of immunosuppression on duration of viremia.Virology, 311 1
P. Meuleman, G. Leroux-Roels (2008)
The human liver-uPA-SCID mouse: a model for the evaluation of antiviral compounds against HBV and HCV.Antiviral research, 80 3
Michael Manns, Heiner Wedemeyer, M. Cornberg (2006)
Treating viral hepatitis C: efficacy, side effects, and complicationsGut, 55
G. Inchauspe, M. Michel, M. Michel (2007)
Vaccines and immunotherapies against hepatitis B and hepatitis C virusesJournal of Viral Hepatitis, 14
R. Lanford, B. Guerra, D. Chavez, Catherine Bigger, K. Brasky, Xiao-hong Wang, S. Ray, David Thomas (2004)
Cross-Genotype Immunity to Hepatitis C VirusJournal of Virology, 78
M. Alter, R. Gerety, L. Smallwood, R. Sampliner, E. Tabor, F. Deinhardt, G. Frösner, G. Matanoski (1982)
Sporadic non-A, non-B hepatitis: frequency and epidemiology in an urban U.S. population.The Journal of infectious diseases, 145 6
C. Firbas, B. Jilma, Erich Tauber, Vera Buerger, S. Jelovcan, K. Lingnau, M. Buschle, J. Frisch, C. Klade (2006)
Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: a randomized, placebo controlled trial for dose optimization in 128 healthy subjects.Vaccine, 24 20
Z. Xie, J. Riezu-Boj, J. Lasarte, J. Guillén, J. Su, M. Civeira, J. Prieto (1998)
Transmission of hepatitis C virus infection to tree shrews.Virology, 244 2
Thomas Wüest, G. Both, A. Prince, C. Hofmann, P. Löser (2004)
Recombinant ovine atadenovirus induces a strong and sustained T cell response against the hepatitis C virus NS3 antigen in mice.Vaccine, 22 21-22
M. Gale, M. Beard (2001)
Molecular clones of hepatitis C virus: applications to animal models.ILAR journal, 42 2
Ying Huang, Jordan Feld, Ronda Sapp, S. Nanda, Jiing‐Huey Lin, L. Blatt, Michael Fried, K. Murthy, T. Liang (2007)
Defective hepatic response to interferon and activation of suppressor of cytokine signaling 3 in chronic hepatitis C.Gastroenterology, 132 2
F. Nevens, T. Roskams, H. Vlierberghe, Y. Horsmans, D. Sprengers, A. Elewaut, V. Desmet, G. Leroux-Roels, E. Quinaux, E. Depla, S. Dincq, C. Stichele, G. Maertens, F. Hulstaert (2003)
A pilot study of therapeutic vaccination with envelope protein E1 in 35 patients with chronic hepatitis CHepatology, 38
A. Prince, B. Brotman, T. Huima, D. Pascual, M. Jaffery, Inchauspé Genevieve (1992)
Immunity in hepatitis C infection.The Journal of infectious diseases, 165 3
M. Major, S. Feinstone (2000)
Characterization of hepatitis C virus infectious clones in chimpanzees: long-term studies.Current topics in microbiology and immunology, 242
M. Puig, M. Major, K. Mihalik, S. Feinstone (2004)
Immunization of chimpanzees with an envelope protein-based vaccine enhances specific humoral and cellular immune responses that delay hepatitis C virus infection.Vaccine, 22 8
N. Lam, A. Neumann, D. Gretch, T. Wiley, A. Perelson, T. Layden (1997)
Dose‐dependent acute clearance of hepatitis C genotype 1 virus with interferon alfaHepatology, 26
K. Blight, A. Kolykhalov, C. Rice (2000)
Efficient initiation of HCV RNA replication in cell culture.Science, 290 5498
S. Ray, Q. Mao, R. Lanford, Suzanne Bassett, O. Laeyendecker, Yu-ming Wang, David Thomas (2000)
Hypervariable Region 1 Sequence Stability during Hepatitis C Virus Replication in ChimpanzeesJournal of Virology, 74
Chimpanzee Management Program
D. O’hagan, Manmohan Singh, Christine Dong, M. Ugozzoli, K. Berger, E. Glazer, M. Selby, M. Wininger, P. Ng, K. Crawford, X. Paliard, S. Coates, M. Houghton (2004)
Cationic microparticles are a potent delivery system for a HCV DNA vaccine.Vaccine, 23 5
D. Moradpour, Petra Kary, C. Rice, H. Blum (1998)
Continuous human cell lines inducibly expressing hepatitis C virus structural and nonstructural proteinsHepatology, 28
L. He, D. Alling, T. Popkin, M. Shapiro, H. Alter, R. Purcell (1987)
Determining the size of non-A, non-B hepatitis virus by filtration.The Journal of infectious diseases, 156 4
M. Frese, T. Pietschmann, D. Moradpour, O. Haller, R. Bartenschlager (2001)
Interferon-alpha inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway.The Journal of general virology, 82 Pt 4
Great Ape Protection Act
R. Bartenschlager, S. Sparacio (2007)
Hepatitis C virus molecular clones and their replication capacity in vivo and in cell culture.Virus research, 127 2
George Wu, M. Konishi, C. Walton, D. Olive, K. Hayashi, Catherine Wu (2005)
A novel immunocompetent rat model of HCV infection and hepatitis.Gastroenterology, 128 5
(2009)
Merck HCV Protease & Polymerase Inhibitor Viral Load Reduction & Resistance in Chimps
Sauer Ug (2000)
Reasons for not using primates in researchALTEX-Alternatives to Animal Experimentation, 17
H. Akari, Y. Iwasaki, Tomoyuki Yoshida, S. Iijima (2009)
Non‐human primate surrogate model of hepatitis C virus infectionMicrobiology and Immunology, 53
R. Bettauer (2010)
Chimpanzees in hepatitis C virus research: 1998–2007Journal of Medical Primatology, 39
Takanobu Kato, T. Matsumura, T. Heller, S. Saito, Ronda Sapp, K. Murthy, T. Wakita, T. Liang (2007)
Production of Infectious Hepatitis C Virus of Various Genotypes in Cell CulturesJournal of Virology, 81
Ying Huang, Y. Uchiyama, T. Fujimura, H. Kanamori, T. Doi, A. Takamizawa, T. Hamakubo, Tatsuhiko Kodama (2001)
A human hepatoma cell line expressing hepatitis c virus nonstructural proteins tightly regulated by tetracycline.Biochemical and biophysical research communications, 281 3
H. Alter (1989)
Chronic Consequences of Non-A, Non-B Hepatitis
M. Guido, F. Bortolotti, G. Leo, P. Jara, L. Hierro, G. Leandro, C. Barbera, R. Giacchino, J. Larrauri, L. Zancan, M. Rugge (2001)
Progression of fibrosis in chronic hepatitis C in children
P. Farci, H. Alter, S. Govindarajan, D. Wong, R. Engle, R. Lesniewski, I. Mushahwar, S. Desai, R. Miller, N. Ogata (1993)
Lack of protective immunity against reinfection with hepatitis C virus.Science, 258 5079
Xiao-yuan Ma, X. Forns, R. Gutierrez, I. Mushahwar, Tong Wu, P. Payette, J. Bukh, R. Purcell, H. Davis (2002)
DNA-based vaccination against hepatitis C virus (HCV): effect of expressing different forms of HCV E2 protein and use of CpG-optimized vectors in mice.Vaccine, 20 27-28
B. Kronenberger, S. Zeuzem (2008)
Future treatment options for HCV: double, triple, what is the optimal combination?Best practice & research. Clinical gastroenterology, 22 6
A. Folgori, S. Capone, L. Ruggeri, A. Meola, E. Sporeno, B. Ercole, M. Pezzanera, R. Tafi, Mirko Arcuri, E. Fattori, A. Lahm, A. Luzzago, A. Vitelli, S. Colloca, R. Cortese, A. Nicosia (2006)
A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzeesNature Medicine, 12
Y. Higashi, S. Kakumu, K. Yoshioka, T. Wakita, M. Mizokami, K. Ohba, Y. Ito, T. Ishikawa, M. Takayanagi, Y. Nagai (1993)
Dynamics of genome change in the E2/NS1 region of hepatitis C virus in vivo.Virology, 197 2
Richard Aach, Wolf Szniuness (1981)
Serum alanine aminotransferase of donors in relation to the risk of non-A,non-B hepatitis in recipients: the transfusion-transmitted viruses study.The New England journal of medicine, 304 17
G. Kuo, Q. Choo, H. Alter, G. Gitnick, A. Redeker, R. Purcell, T. Miyamura, J. Dienstag, M. Alter, C. Stevens (1990)
An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.Science, 244 4902
C. Hui, T. Belaye, Kevin Montegrande, T. Wright (2003)
A comparison in the progression of liver fibrosis in chronic hepatitis C between persistently normal and elevated transaminase.Journal of hepatology, 38 4
J. Kim, X. Wang (2003)
Gene expression profiling of preneoplastic liver disease and liver cancer: a new era for improved early detection and treatment of these deadly diseases?Carcinogenesis, 24 3
S. Maylin, M. Martinot‐Peignoux, R. Moucari, N. Boyer, M. Ripault, D. Cazals‐Hatem, N. Giuily, C. Castelnau, A. Cardoso, T. Asselah, C. Féray, M. Nicolas-Chanoine, P. Bedossa, P. Marcellin (2008)
Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C.Gastroenterology, 135 3
K. Helbig, D. Lau, L. Semendric, H. Harley, M. Beard (2005)
Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effectorHepatology, 42
M. Major, K. Mihalik, M. Puig, B. Rehermann, M. Nascimbeni, C. Rice, S. Feinstone (2002)
Previously Infected and Recovered Chimpanzees Exhibit Rapid Responses That Control Hepatitis C Virus Replication upon RechallengeJournal of Virology, 76
Man Song, Seung Lee, Y. Suh, K. Lee, Y. Sung (2000)
Enhancement of Immunoglobulin G2a and Cytotoxic T-Lymphocyte Responses by a Booster Immunization with Recombinant Hepatitis C Virus E2 Protein in E2 DNA-Primed MiceJournal of Virology, 74
B. Wölk, D. Sansonno, H. Kräusslich, F. Dammacco, C. Rice, H. Blum, D. Moradpour (2000)
Subcellular Localization, Stability, andtrans-Cleavage Competence of the Hepatitis C Virus NS3-NS4A Complex Expressed in Tetracycline-Regulated Cell LinesJournal of Virology, 74
J. Hoofnagle, H. Alter (1985)
Chronic non-A, non-B hepatitis.Progress in clinical and biological research, 182
S. Cooper, A. Erickson, E. Adams, J. Kansopon, A. Weiner, D. Chien, M. Houghton, P. Parham, C. Walker (1999)
Analysis of a successful immune response against hepatitis C virus.Immunity, 10 4
C. Jopling, K. Norman, P. Sarnow (2006)
Positive and negative modulation of viral and cellular mRNAs by liver-specific microRNA miR-122.Cold Spring Harbor symposia on quantitative biology, 71
Chao Lin, Kai Lin, Y. Luong, B. Rao, Yunyi Wei, D. Brennan, J. Fulghum, H. Hsiao, Sue Ma, J. Maxwell, K. Cottrell, R. Perni, C. Gates, A. Kwong (2004)
In Vitro Resistance Studies of Hepatitis C Virus Serine Protease Inhibitors, VX-950 and BILN 2061Journal of Biological Chemistry, 279
X. Forns, J. Bukh, R. Purcell (2002)
The challenge of developing a vaccine against hepatitis C virus.Journal of hepatology, 37 5
S. Jeong, M. Qiao, M. Nascimbeni, Zongyi Hu, B. Rehermann, K. Murthy, T. Liang (2004)
Immunization with Hepatitis C Virus-Like Particles Induces Humoral and Cellular Immune Responses in Nonhuman PrimatesJournal of Virology, 78
M. Thew (2002)
Are results of primate research worth the suffering it causes?Nature, 418
E. Ilan, Joseph Arazi, O. Nussbaum, Arie Zauberman, R. Eren, I. Lubin, L. Neville, O. Ben‐Moshe, A. Kischitzky, A. Litchi, I. Margalit, J. Gopher, S. Mounir, W. Cai, N. Daudi, A. Eid, O. Jurim, A. Czerniak, E. Galun, S. Dagan (2002)
The hepatitis C virus (HCV)-Trimera mouse: a model for evaluation of agents against HCV.The Journal of infectious diseases, 185 2
S. Lee, J. Cho, K. Lee, Y. Sung (1998)
Hepatitis C virus envelope DNA-based immunization elicits humoral and cellular immune responses.Molecules and cells, 8 4
M. Houghton, S. Abrignani (2005)
Prospects for a vaccine against the hepatitis C virusNature, 436
J. Bronowicki, D. Vetter, Georges Uhl, H. Hudziak, Arlette Uhrlacher, J. Vetter, M. Dofföel (1997)
Lymphocyte reactivity to hepatitis C virus (HCV) antigens shows evidence for exposure to HCV in HCV-seronegative spouses of HCV-infected patients.The Journal of infectious diseases, 176 2
S. Barrett, E. Ryan, J. Crowe (1999)
Association of the HLA-DRB1*01 allele with spontaneous viral clearance in an Irish cohort infected with hepatitis C virus via contaminated anti-D immunoglobulin.Journal of hepatology, 30 6
Jane Myung, N. Khalap, G. Kalkeri, R. Garry, S. Dash (2001)
Inducible model to study negative strand RNA synthesis and assembly of hepatitis C virus from a full-length cDNA clone.Journal of virological methods, 94 1-2
S. Dash, Abdel-Baset Halim, Hideyuki Tsuji, Naoki Hiramatsu, Michael Gerber (1997)
Transfection of HepG2 cells with infectious hepatitis C virus genome.The American journal of pathology, 151 2
C. Klade, H. Wedemeyer, T. Berg, H. Hinrichsen, G. Cholewińska, S. Zeuzem, H. Blum, M. Buschle, S. Jelovcan, Vera Buerger, Erich Tauber, J. Frisch, M. Manns (2008)
Therapeutic vaccination of chronic hepatitis C nonresponder patients with the peptide vaccine IC41.Gastroenterology, 134 5
R. Crabbé, G. Vuagniaux, J. Dumont, V. Nicolas‐Métral, J. Marfurt, Laura Novaroli (2009)
An evaluation of the cyclophilin inhibitor Debio 025 and its potential as a treatment for chronic hepatitis CExpert Opinion on Investigational Drugs, 18
V. Rustgi (2009)
Albinterferon alfa-2b, a novel fusion protein of human albumin and human interferon alfa-2b, for chronic hepatitis CCurrent Medical Research and Opinion, 25
Michael Fried1, Stephanos Hadziyannis2 (2004)
Treatment of Chronic Hepatitis C Infection with Peginterferons Plus RibavirinSeminars in Liver Disease, 24
V. Castet, C. Fournier, A. Soulier, R. Brillet, J. Coste, D. Larrey, D. Dhumeaux, P. Maurel, J. Pawlotsky (2002)
Alpha Interferon Inhibits Hepatitis C Virus Replication in Primary Human Hepatocytes Infected In VitroJournal of Virology, 76
N. Grüner, T. Gerlach, M. Jung, H. Diepolder, C. Schirren, W. Schraut, R. Hoffmann, R. Zachoval, T. Santantonio, M. Cucchiarini, A. Cerny, G. Pape (2000)
Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C.The Journal of infectious diseases, 181 5
Robert Lanford, Helen Lee, D. Chavez, B. Guerra, K. Brasky (2001)
Infectious cDNA clone of the hepatitis C virus genotype 1 prototype sequence.The Journal of general virology, 82 Pt 6
Y. Shimizu, H. Yoshikura (1994)
Multicycle infection of hepatitis C virus in cell culture and inhibition by alpha and beta interferonsJournal of Virology, 68
M. Esumi, T. Rikihisa, S. Nishimura, J. Goto, K. Mizuno, Y-H Zhou, T. Shikata (1999)
Experimental vaccine activities of recombinant E1 and E2 glycoproteins and hypervariable region 1 peptides of hepatitis C virus in chimpanzeesArchives of Virology, 144
R. Flisiak, A. Horban, P. Gallay, M. Bobardt, S. Selvarajah, A. Wiercińska-Drapało, E. Siwak, I. Cielniak, J. Higersberger, J. Kierkuś, C. Aeschlimann, P. Grosgurin, V. Nicolas‐Métral, J. Dumont, H. Porchet, R. Crabbé, P. Scalfaro (2008)
The cyclophilin inhibitor Debio‐025 shows potent anti–hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virusHepatology, 47
A. Kolykhalov, K. Mihalik, S. Feinstone, C. Rice (2000)
Hepatitis C Virus-Encoded Enzymatic Activities and Conserved RNA Elements in the 3′ Nontranslated Region Are Essential for Virus Replication In VivoJournal of Virology, 74
A. Neumann, N. Lam, H. Dahari, D. Gretch, T. Wiley, T. Layden, A. Perelson (1998)
Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy.Science, 282 5386
S. Hadziyannis, H. Sette, T. Morgan, V. Balan, M. Diago, P. Marcellin, G. Ramadori, H. Bodenheimer, D. Bernstein, M. Rizzetto, S. Zeuzem, P. Pockros, A. Lin, A. Ackrill (2004)
Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose.Annals of internal medicine, 140 5
S. Crotta, A. Stilla, A. Wack, A. D’Andrea, S. Nuti, U. D’Oro, M. Mosca, Franco Filliponi, R. Brunetto, F. Bonino, S. Abrignani, N. Valiante (2002)
Inhibition of Natural Killer Cells through Engagement of CD81 by the Major Hepatitis C Virus Envelope ProteinThe Journal of Experimental Medicine, 195
R. Chung, Wenping He, Afroz Saquib, A. Contreras, R. Xavier, Ashish Chawla, T. Wang, E. Schmidt (2001)
Hepatitis C virus replication is directly inhibited by IFN-α in a full-length binary expression systemProceedings of the National Academy of Sciences of the United States of America, 98
Dimitri Lavillette, Y. Morice, G. Germanidis, P. Donot, A. Soulier, E. Pagkalos, G. Sakellariou, L. Intrator, B. Bartosch, J. Pawlotsky, F. Cosset (2005)
Human Serum Facilitates Hepatitis C Virus Infection, and Neutralizing Responses Inversely Correlate with Viral Replication Kinetics at the Acute Phase of Hepatitis C Virus InfectionJournal of Virology, 79
Joacim Elmén, M. Lindow, Sylvia Schütz, M. Lawrence, A. Petri, S. Obad, M. Lindholm, Maj Hedtjärn, H. Hansen, U. Berger, S. Gullans, P. Kearney, P. Sarnow, E. Straarup, S. Kauppinen (2008)
LNA-mediated microRNA silencing in non-human primatesNature, 452
G. Inchauspe, M. Major, Isao Nakano, Ludmila Vitvitski, C. Trepo (1997)
DNA vaccination for the induction of immune responses against hepatitis C virus proteins.Vaccine, 15 8
A. Neumann, N. Lam, H. Dahari, D. Gretch, T. Wiley, T. Layden, A. Perelson (1998)
Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α TherapyScience, 282
S. Carroll, S. Ludmerer, L. Handt, K. Koeplinger, N. Zhang, D. Graham, M. Davies, M. Maccoss, D. Hazuda, D. Olsen (2008)
Robust Antiviral Efficacy upon Administration of a Nucleoside Analog to Hepatitis C Virus-Infected ChimpanzeesAntimicrobial Agents and Chemotherapy, 53
Koichi Watashi, Naoto Ishii, M. Hijikata, D. Inoue, T. Murata, Yusuke Miyanari, K. Shimotohno (2005)
Cyclophilin B is a functional regulator of hepatitis C virus RNA polymerase.Molecular cell, 19 1
J. Dienstag, J. McHutchinson (2006)
Continuing Medical Education Exam 3: January 2006: AGA Medical Position Statement and Technical ReviewGastroenterology, 130
Lotte Coelmont, J. Paeshuyse, M. Windisch, E. Clercq, R. Bartenschlager, J. Neyts (2006)
Ribavirin Antagonizes the In Vitro Anti-Hepatitis C Virus Activity of 2′-C-Methylcytidine, the Active Component of ValopicitabineAntimicrobial Agents and Chemotherapy, 50
D. Kremsdorf, Nicolas Brezillon (2007)
New animal models for hepatitis C viral infection and pathogenesis studies.World journal of gastroenterology, 13 17
J. Nam, K. Faulk, R. Engle, S. Govindarajan, M. Claire, J. Bukh (2004)
In Vivo Analysis of the 3′ Untranslated Region of GB Virus B after In Vitro Mutagenesis of an Infectious cDNA Clone: Persistent Infection in a Transfected TamarinJournal of Virology, 78
G. Elmowalid, M. Qiao, S. Jeong, B. Borg, T. Baumert, Ronda Sapp, Zongyi Hu, K. Murthy, T. Liang (2007)
Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzeesProceedings of the National Academy of Sciences, 104
S. Caldwell (2001)
Controlling pain in liver biopsy, or “we will probably need to repeat the biopsy in a year or two to assess the response”American Journal of Gastroenterology, 96
A. Cerny, F. Chisari (1999)
Pathogenesis of chronic hepatitis C: Immunological features of hepatic injury and viral persistenceHepatology, 30
M. Beard, Geoff Abell, M. Honda, Anthony Carroll, M. Gartland, B. Clarke, Koyu Suzuki, R. Lanford, D. Sangar, S. Lemon (1999)
An infectious molecular clone of a Japanese genotype 1b hepatitis C virusHepatology, 30
K. Krawczyński, M. Alter, D. Tankersley, M. Beach, B. Robertson, S. Lambert, G. Kuo, J. Spelbring, Emory Meeks, Saswati Sinha, D. Carson (1996)
Effect of immune globulin on the prevention of experimental hepatitis C virus infection.The Journal of infectious diseases, 173 4
M. Houghton (2009)
Discovery of the hepatitis C virusLiver International, 29
J. Heathcote, J. Main (2005)
Treatment of hepatitis CJournal of Viral Hepatitis, 12
P. Marcellin, N. Boyer, A. Gervais, M. Martinot, M. Pouteau, C. Castelnau, A. Kilani, J. Areias, A. Aupérin, J. Benhamou, C. Degott, S. Erlinger (1997)
Long-Term Histologic Improvement and Loss of Detectable Intrahepatic HCV RNA in Patients with Chronic Hepatitis C and Sustained Response to Interferon- TherapyAnnals of Internal Medicine, 127
N. Ryder (2010)
Discontinued drugs in 2008: anti-infectivesExpert Opinion on Investigational Drugs, 19
B. Lindenbach, M. Evans, A. Syder, B. Wölk, T. Tellinghuisen, Christopher Liu, T. Maruyama, R. Hynes, D. Burton, J. McKeating, C. Rice (2005)
Complete Replication of Hepatitis C Virus in Cell CultureScience, 309
D. Standring, R. Lanford, B. Li, R. Panzo, M. Seifer, M. Larsson, S. Good, X. Zhou (2009)
91 ANTIVIRAL ACTIVITY OF THE LIVER-TARGETED NUCLEOTIDE HCV POLYMERASE INHIBITOR IDX184 CORRELATES WITH TROUGH SERUM LEVELS OF THE NUCLEOSIDE METABOLITE IN HCV-INFECTED CHIMPANZEESJournal of Hepatology, 50
G. Bradshaw, T. Capaldo, Lorin Lindner, Gloria Grow (2008)
Building an Inner Sanctuary: Complex PTSD in ChimpanzeesJournal of Trauma & Dissociation, 9
J. Bukh (2004)
A critical role for the chimpanzee model in the study of hepatitis CHepatology, 39
J. Rossignol, A. Elfert, Y. el-Gohary, E. Keeffe (2009)
Improved virologic response in chronic hepatitis C genotype 4 treated with nitazoxanide, peginterferon, and ribavirin.Gastroenterology, 136 3
D. Mercer, D. Schiller, J. Elliott, D. Douglas, C. Hao, A. Rinfret, W. Addison, K. Fischer, T. Churchill, J. Lakey, D. Tyrrell, N. Kneteman (2001)
Hepatitis C virus replication in mice with chimeric human liversNature Medicine, 7
H. Alter, P. Holland, A. Morrow, R. Purcell, S. Feinstone, Y. Moritsugu (1975)
CLINICAL AND SEROLOGICAL ANALYSIS OF TRANSFUSION-ASSOCIATED HEPATITISThe Lancet, 306
Su‐Hyung Park, Se‐Hwan Yang, Chang Lee, J. Youn, Jun Chang, Y. Sung (2003)
Efficient induction of T helper 1 CD4+ T-cell responses to hepatitis C virus core and E2 by a DNA prime-adenovirus boost.Vaccine, 21 31
O. Engler, R. Schwendener, W. Dai, B. Wölk, W. Pichler, D. Moradpour, T. Brunner, A. Cerny (2004)
A liposomal peptide vaccine inducing CD8+ T cells in HLA-A2.1 transgenic mice, which recognise human cells encoding hepatitis C virus (HCV) proteins.Vaccine, 23 1
(2002)
Dutch Lab Chimps to be Retired. Summerville, SC, USA: International Primate Protection League
T. Poynard, P. Bedossa, P. Opolon (1997)
Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups.Lancet, 349 9055
S. Perri, C. Greer, K. Thudium, B. Doe, H. Legg, Hong Liu, R. Romero, Z. Tang, Q. Bin, T. Dubensky, M. Vajdy, G. Otten, J. Polo (2003)
An Alphavirus Replicon Particle Chimera Derived from Venezuelan Equine Encephalitis and Sindbis Viruses Is a Potent Gene-Based Vaccine Delivery VectorJournal of Virology, 77
S. Der, Aimin Zhou, B. Williams, R. Silverman (1998)
Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arraysProceedings of the National Academy of Sciences of the United States of America, 95
C. Tseng, G. Klimpel (2002)
Binding of the Hepatitis C Virus Envelope Protein E2 to CD81 Inhibits Natural Killer Cell FunctionsThe Journal of Experimental Medicine, 195
D. Bowen, C. Walker (2005)
Adaptive immune responses in acute and chronic hepatitis C virus infectionNature, 436
Ju-Tao Guo, V. Bichko, C. Seeger (2001)
Effect of Alpha Interferon on the Hepatitis C Virus RepliconJournal of Virology, 75
H. Lerat, F. Berby, M. Trabaud, O. Vidalin, M. Major, C. Trépo, G. Inchauspe (1996)
Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells.The Journal of clinical investigation, 97 3
A. Takamizawa, C. Mori, I. Fuke, S. Manabe, S. Murakami, J. Fujita, E. Onishi, T. Andoh, I. Yoshida, Hiroto Okayama (1991)
Structure and organization of the hepatitis C virus genome isolated from human carriersJournal of Virology, 65
S. Yutani, A. Yamada, K. Yoshida, Y. Takao, M. Tamura, N. Komatsu, T. Ide, Masatoshi Tanaka, M. Sata, K. Itoh (2007)
Phase I clinical study of a personalized peptide vaccination for patients infected with hepatitis C virus (HCV) 1b who failed to respond to interferon-based therapy.Vaccine, 25 42
T. Hahn, J. Yoon, H. Alter, C. Rice, B. Rehermann, P. Balfe, J. McKeating (2007)
Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo.Gastroenterology, 132 2
(1995)
Mother‐to‐infant transmission of hepatitis C virusInternational Journal of Gynecology & Obstetrics, 51
(2007)
Chimp anzee Research: An Examination of Its Cont ribution to Biomedical Knowledge and Efficacy in Combating Human Diseases, 47pp. Boston, MA, USA: New England Anti-Vivisection Society (Project R&R)
A. Su, J. Pezacki, L. Wodicka, A. Brideau, L. Supeková, R. Thimme, S. Wieland, J. Bukh, R. Purcell, P. Schultz, F. Chisari (2002)
Genomic analysis of the host response to hepatitis C virus infectionProceedings of the National Academy of Sciences of the United States of America, 99
N. Yao, T. Hesson, M. Cable, Z. Hong, A. Kwong, H. Le, P. Weber (1997)
Structure of the hepatitis C virus RNA helicase domainNature Structural Biology, 4
Krystle Lang, D. Weiner (2008)
Immunotherapy for HCV infection: next stepsExpert Review of Vaccines, 7
R Moormann, H. Gennip, G. Miedema, M. Hulst, P. Rijn (1996)
Infectious RNA transcribed from an engineered full-length cDNA template of the genome of a pestivirusJournal of Virology, 70
A. Sakai, S. Takikawa, R. Thimme, J. Meunier, H. Spangenberg, S. Govindarajan, P. Farci, S. Emerson, F. Chisari, R. Purcell, J. Bukh (2007)
In Vivo Study of the HC-TN Strain of Hepatitis C Virus Recovered from a Patient with Fulminant Hepatitis: RNA Transcripts of a Molecular Clone (pHC-TN) Are Infectious in Chimpanzees but Not in Huh7.5 CellsJournal of Virology, 81
Y. Shimizu, H. Igarashi, T. Kiyohara, M. Shapiro, D. Wong, R. Purcell, H. Yoshikura (1998)
Infection of a chimpanzee with hepatitis C virus grown in cell culture.The Journal of general virology, 79 ( Pt 6)
R. Gish, Sanjeev Arora, K. Reddy, D. Nelson, C. O’Brien, Yi Xu, B. Murphy (2007)
Virological response and safety outcomes in therapy-nai ve patients treated for chronic hepatitis C with taribavirin or ribavirin in combination with pegylated interferon alfa-2a: a randomized, phase 2 study.Journal of hepatology, 47 1
(2008)
End Chimpanzee Research: Overview -International Bans
Jon Cohen (2007)
Biomedical research. The endangered lab chimp.Science, 315 5811
L. Leede, J. Humphries, A. Bechet, E. Hoogdalem, R. Verrijk, D. Spencer (2008)
Novel controlled-release Lemna-derived IFN-alpha2b (Locteron): pharmacokinetics, pharmacodynamics, and tolerability in a phase I clinical trial.Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, 28 2
D. Olsen, S. Carroll, L. Handt, S. Ludmerer, D. Graham, Christine Fandozzi, J. Deluca, N. Liverton, J. Vacca, D. Hazuda (2007)
[791] HCV ANTIVIRAL ACTIVITY AND RESISTANCE ANALYSIS IN CHRONICALLY INFECTED CHIMPANZEES TREATED WITH NS3/4A PROTEASE AND NS5B POLYMERASE INHIBITORSJournal of Hepatology, 46
Y. Jeong, B. Kim (2003)
Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C Virus Infection
F. Chisari (1997)
Cytotoxic T cells and viral hepatitis.The Journal of clinical investigation, 99 7
J. Bukh, T. Pietschmann, V. Lohmann, Nicole Krieger, K. Faulk, R. Engle, S. Govindarajan, M. Shapiro, M. Claire, R. Bartenschlager (2002)
Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzeesProceedings of the National Academy of Sciences of the United States of America, 99
Suzanne Bassett, David Thomas, K. Brasky, R. Lanford (1999)
Viral Persistence, Antibody to E1 and E2, and Hypervariable Region 1 Sequence Stability in Hepatitis C Virus-Inoculated ChimpanzeesJournal of Virology, 73
R. Combes, T. Berridge, J. Connelly, M. Eve, R. Garner, S. Toon, P. Wilcox (2003)
Early microdose drug studies in human volunteers can minimise animal testing: Proceedings of a workshop organised by Volunteers in Research and Testing.European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 19 1
C. Lin, A. Kwong, R. Perni (2006)
Discovery and development of VX-950, a novel, covalent, and reversible inhibitor of hepatitis C virus NS3.4A serine protease.Infectious disorders drug targets, 6 1
T. Wakita, T. Pietschmann, Takanobu Kato, Takanobu Kato, T. Date, M. Miyamoto, Zijiang Zhao, K. Murthy, A. Habermann, H. Kräusslich, M. Mizokami, R. Bartenschlager, T. Liang (2005)
Production of infectious hepatitis C virus in tissue culture from a cloned viral genomeNature Medicine, 11
(2008)
Fearful Knockdowns
F. Stoll-Keller, H. Barth, S. Fafi-Kremer, M. Zeisel, T. Baumert (2009)
Development of hepatitis C virus vaccines: challenges and progressExpert Review of Vaccines, 8
N. Ryder (2009)
Discontinued drugs in 2007: anti-infectives.Expert opinion on investigational drugs, 18 1
G. Davis, D. Nelson, N. Terrault, T. Pruett, T. Schiano, C. Fletcher, C. Sapan, L. Riser, Yufeng Li, R. Whitley, J. Gnann (2005)
A randomized, open‐label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipientsLiver Transplantation, 11
A. Muir, J. Bornstein, P. Killenberg (2004)
Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites.The New England journal of medicine, 350 22
New Anti-Vivisection (2011)
An Assessment of the Use of Chimpanzees in Hepatitis C Research Past , Present and Future : 2 . Alternative Replacement Methods
D. Standring, R. Lanford, T. Wright, R. Chung, V. Bichko, E. Cretton-scott, X. Pan-Zhou, S. Bergelson, Lin Qu, M. Tausek, E. Bridges, A. Moussa, R. Storer, C. Pierra, S. Benzaria, G. Gosselin, P. Colla, J. Sommadossi (2003)
NM 283 has potent antiviral activity against genotype 1 chronic hepatitis C virus (HCV-1) infection in the chimpanzeeJournal of Hepatology, 38
C. Brinster, Margaret Chen, D. Boucreux, G. Paranhos-Baccalà, P. Liljeström, F. Lemmonier, G. Inchauspe (2002)
Hepatitis C virus non-structural protein 3-specific cellular immune responses following single or combined immunization with DNA or recombinant Semliki Forest virus particles.The Journal of general virology, 83 Pt 2
S. Der, A. Zhou, B. Williams, R. Silverman (1998)
Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays.Proceedings of the National Academy of Sciences of the United States of America, 95 26
H. Mo, L. Lu, T. Pilot-matias, R. Pithawalla, Rubina Mondal, Sherie Masse, T. Dekhtyar, T. Ng, G. Koev, V. Stoll, K. Stewart, J. Pratt, Pamela Donner, T. Rockway, C. Maring, A. Molla (2005)
Mutations Conferring Resistance to a Hepatitis C Virus (HCV) RNA-Dependent RNA Polymerase Inhibitor Alone or in Combination with an HCV Serine Protease Inhibitor In VitroAntimicrobial Agents and Chemotherapy, 49
X. Forns, P. Payette, Xiao-yuan Ma, W. Satterfield, G. Eder, I. Mushahwar, S. Govindarajan, H. Davis, S. Emerson, R. Purcell, J. Bukh (2000)
Vaccination of Chimpanzees With Plasmid DNA Encoding the Hepatitis C Virus (HCV) Envelope E2 Protein Modified the Infection After Challenge With Homologous Monoclonal HCVHepatology, 32
(2007)
Transportation, sale, and handling of certain animals
J. Gilliam, K. Geisinger, J. Richter (1984)
Primary hepatocellular carcinoma after chronic non-A, non-B post-transfusion hepatitis.Annals of internal medicine, 101 6
J. Pawlotsky, J. McHutchison (2004)
Hepatitis C. Development of new drugs and clinical trials: Promises and pitfalls. Summary of an AASLD hepatitis single topic conference, Chicago, IL, February 27–March 1, 2003Hepatology, 39
M. Major, Ludmila Vitvitski, M. Mink, M. Schleef, R. Whalen, C. Trepo, G. Inchauspe (1995)
DNA-based immunization with chimeric vectors for the induction of immune responses against the hepatitis C virus nucleocapsidJournal of Virology, 69
H. Alter, R. Purcell, J. Shih, J. Melpolder, M. Houghton, Q. Choo, G. Kuo (1989)
Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.The New England journal of medicine, 321 22
H. Alter, P. Holland, R. Purcell, H. Popper (1978)
TRANSMISSIBLE AGENT IN NON-A, NON-B HEPATITISThe Lancet, 311
S. Feinstone, A. Kapikian, R. Purcell, H. Alter, P. Holland (1975)
Transfusion-associated hepatitis not due to viral hepatitis type A or B. 1975.Reviews in medical virology, 11 1
P. Brown-Augsburger, Xin Yue, Jennifer Lockridge, J. Mcswiggen, Dimple Kamboj, K. Hillgren (2004)
Development and validation of a sensitive, specific, and rapid hybridization-ELISA assay for determination of concentrations of a ribozyme in biological matrices.Journal of pharmaceutical and biomedical analysis, 34 1
P. Scognamiglio, D. Accapezzato, Marco Casciaro, A. Cacciani, M. Artini, G. Bruno, Maria Chircu, J. Sidney, S. Southwood, S. Abrignani, A. Sette, V. Barnaba (1999)
Presence of effector CD8+ T cells in hepatitis C virus-exposed healthy seronegative donors.Journal of immunology, 162 11
V. Schlaphoff, C. Klade, B. Jilma, S. Jelovcan, M. Cornberg, Erich Tauber, M. Manns, H. Wedemeyer (2007)
Functional and phenotypic characterization of peptide-vaccine-induced HCV-specific CD8+ T cells in healthy individuals and chronic hepatitis C patients.Vaccine, 25 37-38
N. Fujita, M. Kaito, M. Takeo, M. Iwasa, J. Ikoma, Shozo Watanabe, Y. Adachi (2003)
Nonimmune Complexed HCV RNA Titer in Serum as a Predictor of Interferon Response in Patients With Chronic Hepatitis CAmerican Journal of Gastroenterology, 98
(2005)
Public Opinion of Chimpanzee Research, Support for a Ban, and Related Issues
H. Netter, T. Macnaughton, W. Woo, R. Tindle, E. Gowans (2001)
Antigenicity and Immunogenicity of Novel Chimeric Hepatitis B Surface Antigen Particles with Exposed Hepatitis C Virus EpitopesJournal of Virology, 75
D. Dhumeaux, P. Marcellin, É. Lerebours (2003)
Treatment of hepatitis C. The 2002 French consensusGut, 52
B. Blumberg, H. Alter, S. Visnich (1965)
A "NEW" ANTIGEN IN LEUKEMIA SERA.JAMA, 191
G. MacQuillan, C. Mamotte, W. Reed, G. Jeffrey, J. Allan (2003)
Upregulation of endogenous intrahepatic interferon stimulated genes during chronic hepatitis C virus infectionJournal of Medical Virology, 70
G. Leroux-Roels, E. Depla, F. Hulstaert, L. Tobback, S. Dincq, Jaques Desmet, I. Desombere, G. Maertens (2004)
A candidate vaccine based on the hepatitis C E1 protein: tolerability and immunogenicity in healthy volunteers.Vaccine, 22 23-24
Mohamed Hassan, D. Selimović, H. Ghozlan, O. Abdelkader (2009)
Hepatitis C virus core protein triggers hepatic angiogenesis by a mechanism including multiple pathwaysHepatology, 49
P. Marcellin (2009)
Hepatitis B and hepatitis C in 2009Liver International, 29
Jarrod Bailey (2010)
An Assessment of the Use of Chimpanzees in Hepatitis C Research Past, Present and Future: 2. Alternative Replacement MethodsAlternatives to Laboratory Animals, 38
Joacim Elmén, M. Lindow, A. Silahtaroglu, M. Bak, M. Christensen, A. Lind-Thomsen, Maj Hedtjärn, J. Hansen, H. Hansen, E. Straarup, Keith McCullagh, P. Kearney, S. Kauppinen (2007)
Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liverNucleic Acids Research, 36
P. Meuleman, L. Libbrecht, R. vos, B. Hemptinne, K. Gevaert, J. Vandekerckhove, T. Roskams, G. Leroux-Roels (2005)
Morphological and biochemical characterization of a human liver in a uPA‐SCID mouse chimeraHepatology, 41
B. Malcolm, Rong Liu, F. Lahser, S. Agrawal, B. Belanger, N. Butkiewicz, R. Chase, F. Gheyas, A. Hart, D. Hesk, P. Ingravallo, C. Jiang, R. Kong, J. Lu, J. Pichardo, A. Prongay, A. Skelton, X. Tong, S. Venkatraman, E. Xia, V. Girijavallabhan, F. Njoroge (2006)
SCH 503034, a Mechanism-Based Inhibitor of Hepatitis C Virus NS3 Protease, Suppresses Polyprotein Maturation and Enhances the Antiviral Activity of Alpha Interferon in Replicon CellsAntimicrobial Agents and Chemotherapy, 50
Jarrod Bailey (2005)
Non-Human Primates in Medical Research and Drug Development: A Critical ReviewBiogenic Amines, 19
K. Walters, M. Katze (2009)
Using high-throughput genomics to study hepatitis C: what determines the outcome of infection?Antiviral research, 81 3
Ethel Gordon, Ramesh Bhat, Qingyan Liu, Yun-Fen Wang, Charles Tackney, A. Prince (2000)
Immune responses to hepatitis C virus structural and nonstructural proteins induced by plasmid DNA immunizations.The Journal of infectious diseases, 181 1
G. González-Aseguinolaza, J. Crettaz, L. Ochoa, I. Otano, R. Aldabe, A. Pañeda (2006)
Gene therapy for viral hepatitisExpert Opinion on Biological Therapy, 6
J. Feld, J. Hoofnagle (2005)
Mechanism of action of interferon and ribavirin in treatment of hepatitis CNature, 436
V. Agnello, F. Rosa (2004)
Extrahepatic disease manifestations of HCV infection: some current issues.Journal of hepatology, 40 2
T. Schiano, M. Charlton, Z. Younossi, E. Galun, T. Pruett, R. Tur-kaspa, R. Eren, S. Dagan, N. Graham, Paulette Williams, J. Andrews (2006)
Monoclonal antibody HCV‐AbXTL68 in patients undergoing liver transplantation for HCV: Results of a phase 2 randomized studyLiver Transplantation, 12
Nassim Usman, Lawrence Blatt (2000)
Nuclease-resistant synthetic ribozymes: developing a new class of therapeutics.The Journal of clinical investigation, 106 10
A. Prince, B. Brotman, Dong-Hun Lee, Leigh Ren, Bonnie Moore, James Scheffel (1999)
Significance of the anti-E2 response in self-limited and chronic hepatitis C virus infections in chimpanzees and in humans.The Journal of infectious diseases, 180 4
(2010)
SPC3649 Multiple Dose Study in Healthy Volunteers
J. Bukh, R. Thimme, J. Meunier, K. Faulk, H. Spangenberg, Kyong‐Mi Chang, W. Satterfield, F. Chisari, R. Purcell (2008)
Previously Infected Chimpanzees Are Not Consistently Protected against Reinfection or Persistent Infection after Reexposure to the Identical Hepatitis C Virus StrainJournal of Virology, 82
Suzanne Bassett, B. Guerra, K. Brasky, E. Miskovsky, M. Houghton, G. Klimpel, R. Lanford (2001)
Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infectionHepatology, 33
M. Barria, Jorge Vera-Otarola, Ursula León, V. Vollrath, D. Marsac, A. Riquelme, M. López-Lastra, A. Soza (2008)
Influence of extrahepatic viral infection on the natural history of hepatitis C.Annals of hepatology, 7 2
C. Jopling, M. Yi, A. Lancaster, S. Lemon, P. Sarnow (2005)
Modulation of Hepatitis C Virus RNA Abundance by a Liver-Specific MicroRNAScience, 309
Maria Smith, Zhaoxia Yue, M. Korth, H. Do, L. Boix, N. Fausto, J. Bruix, R. Carithers, M. Katze (2003)
Hepatitis C virus and liver disease: Global transcriptional profiling and identification of potential markersHepatology, 38
R. Lanford, Catherine Bigger (2002)
Advances in model systems for hepatitis C virus research.Virology, 293 1
G. Inchauspe, M. Major, I. Nakano, L. Vivitski, M. Maisonnas, C. Trépo (1998)
Immune responses against hepatitis C virus structural proteins following genetic immunisation.Developments in biological standardization, 92
M. Meyer, M. Lehmann, M. Cornberg, J. Wiegand, M. Manns, C. Klade, H. Wedemeyer (2007)
Clearance of low levels of HCV viremia in the absence of a strong adaptive immune responseVirology Journal, 4
R. Francesco, P. Neddermann, L. Tomei, C. Steinkühler, P. Gallinari, A. Folgori (2000)
Biochemical and Immunologic Properties of the Nonstructural Proteins of the Hepatitis C Virus: Implications for Development of Antiviral Agents and VaccinesSEMINARS IN LIVER DISEASE, Volume 20
Masayuki Yanagi, Robert Purcell, S. Emerson, J. Bukh (1997)
Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee.Proceedings of the National Academy of Sciences of the United States of America, 94 16
M. Matsui, O. Moriya, T. Akatsuka (2003)
Enhanced induction of hepatitis C virus-specific cytotoxic T lymphocytes and protective efficacy in mice by DNA vaccination followed by adenovirus boosting in combination with the interleukin-12 expression plasmid.Vaccine, 21 15
N. Ryder (2007)
Discontinued drugs in 2006: anti-infectivesExpert Opinion on Investigational Drugs, 16
H. Diepolder, R. Zachoval, R. Hoffmann, M. Jung, T. Gerlach, G. Pape (1996)
The role of hepatitis C virus specific CD4+ T lymphocytes in acute and chronic hepatitis CJournal of Molecular Medicine, 74
M. Albert, J. Decalf, S. Pol (2008)
Plasmacytoid dendritic cells move down on the list of suspects: in search of the immune pathogenesis of chronic hepatitis C.Journal of hepatology, 49 6
H. Hinrichsen, Y. Benhamou, H. Wedemeyer, M. Reiser, R. Sentjens, J. Calleja, X. Forns, A. Erhardt, J. Crönlein, R. Chaves, C. Yong, G. Nehmiz, G. Steinmann (2004)
Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients.Gastroenterology, 127 5
Byoung Yoo, M. Selby, J. Choe, B. Suh, Steven Choi, Jean Joh, G. Nuovo, Hyo‐Suk Lee, M. Houghton, Jang Han (1995)
Transfection of a differentiated human hepatoma cell line (Huh7) with in vitro-transcribed hepatitis C virus (HCV) RNA and establishment of a long-term culture persistently infected with HCVJournal of Virology, 69
V. Soriano, M. Peters, S. Zeuzem (2009)
New therapies for hepatitis C virus infection.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 48 3
A. Haberstroh, E. Schnober, M. Zeisel, P. Carolla, H. Barth, H. Blum, F. Cosset, G. Koutsoudakis, R. Bartenschlager, A. Union, E. Depla, A. Owsianka, A. Patel, C. Schuster, F. Stoll-Keller, M. Dofföel, M. Dreux, T. Baumert (2008)
Neutralizing host responses in hepatitis C virus infection target viral entry at postbinding steps and membrane fusion.Gastroenterology, 135 5
S. Geller (2002)
Hepatitis B and hepatitis C.Clinics in liver disease, 6 2
X. Ji, R. Cheung, S. Cooper, Qingqin Li, H. Greenberg, Xiaosong He (2003)
Interferon alfa regulated gene expression in patients initiating interferon treatment for chronic hepatitis CHepatology, 37
J. Pestka, M. Zeisel, E. Bläser, P. Schürmann, B. Bartosch, F. Cosset, A. Patel, H. Meisel, J. Baumert, S. Viazov, K. Rispeter, H. Blum, M. Roggendorf, T. Baumert (2007)
Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis CProceedings of the National Academy of Sciences, 104
F. Lechner, D. Wong, P. Dunbar, R. Chapman, R. Chung, P. Dohrenwend, G. Robbins, R. Phillips, P. Klenerman, B. Walker (2000)
Analysis of Successful Immune Responses in Persons Infected with Hepatitis C VirusThe Journal of Experimental Medicine, 191
P. Pancholi, M. Perkus, N. Tricoche, Qingyan Liu, A. Prince (2003)
DNA Immunization with Hepatitis C Virus (HCV) Polycistronic Genes or Immunization by HCV DNA Priming-Recombinant Canarypox Virus Boosting Induces Immune Responses and Protection from Recombinant HCV-Vaccinia Virus Infection in HLA-A2.1-Transgenic MiceJournal of Virology, 77
M. Frese, T. Pietschmann, D. Moradpour, O. Haller, R. Bartenschlager (2001)
Interferon-α inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathwayJournal of General Virology, 82
P. Simmonds, J. Bukh, C. Combet, G. Deléage, N. Enomoto, S. Feinstone, P. Halfon, G. Inchauspe, Carla Kuiken, G. Maertens, M. Mizokami, D. Murphy, H. Okamoto, J. Pawlotsky, F. Penin, E. Sablon, T. Shin-I, L. Stuyver, H. Thiel, S. Viazov, A. Weiner, A. Widell (2005)
Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypesHepatology, 42
S. Pfeffer, T. Baumert (2009)
Unravelling the importance of microRNAs during hepatitis C virus infection in the human liver.Journal of hepatology, 51 3
T. Morita, H. Hada, N. Koide, H. Shiraha, T. Shinji, M. Nakamura, K. Ujike, M. Wato, H. Shimomura, T. Tsuji (1996)
Detection of hepatitis C virus RNA in circulating immune complexes by RT-PCR.Hepato-gastroenterology, 43 9
T. Asselah, Y. Benhamou, P. Marcellin (2009)
Protease and polymerase inhibitors for the treatment of hepatitis CLiver International, 29
J. Youn, Su‐Hyung Park, Dimitri Lavillette, F. Cosset, Se‐Hwan Yang, Chang Lee, H. Jin, Chang‐Min Kim, M. Shata, Dong‐Hun Lee, W. Pfahler, A. Prince, Y. Sung (2005)
Sustained E2 antibody response correlates with reduced peak viremia after hepatitis C virus infection in the chimpanzeeHepatology, 42
R. Lanford, B. Guerra, Helen Lee, D. Averett, Brad Pfeiffer, D. Chavez, L. Notvall, Catherine Bigger (2003)
Antiviral Effect and Virus-Host Interactions in Response to Alpha Interferon, Gamma Interferon, Poly(I)-Poly(C), Tumor Necrosis Factor Alpha, and Ribavirin in Hepatitis C Virus Subgenomic RepliconsJournal of Virology, 77
(2009)
Antiviral Activity and Safety of 3 Different Doses of Mifepristone in Hepatitis C Infected Patients
S. Feinstone, K. Mihalik, '. Tomoteru, Kamimura, J. Harvey, Alter, W. London (1983)
Inactivation of hepatitis B virus and non-A, non-B hepatitis by chloroformInfection and Immunity, 41
Masayuki Yanagi, Marisa Claire, S. Emerson, Robert Purcell, Jens Bukh (1999)
In vivo analysis of the 3' untranslated region of the hepatitis C virus after in vitro mutagenesis of an infectious cDNA clone.Proceedings of the National Academy of Sciences of the United States of America, 96 5
P. Sheehy, B. Mullan, I. Moreau, E. Kenny‐Walsh, F. Shanahan, M. Scallan, L. Fanning (2007)
In vitro replication models for the hepatitis C virusJournal of Viral Hepatitis, 14
L. Lu, T. Dekhtyar, Sherie Masse, R. Pithawalla, Preethi Krishnan, Wenping He, T. Ng, G. Koev, K. Stewart, D. Larson, Todd Bosse, R. Wagner, T. Pilot-matias, H. Mo, A. Molla (2007)
Identification and characterization of mutations conferring resistance to an HCV RNA-dependent RNA polymerase inhibitor in vitro.Antiviral research, 76 1
Masayuki Yanagi, Marisa Claire, M. Shapiro, S. Emerson, Robert Purcell, Jens Bukh (1998)
Transcripts of a chimeric cDNA clone of hepatitis C virus genotype 1b are infectious in vivo.Virology, 244 1
R. Levine, S. Sanderson, R. Ploutz-Snyder, F. Murray, E. Kay, J. Hegarty, N. Nolan, D. Kelleher, G. McDonald, J. O’keane, J. Crowe (2006)
Assessment of fibrosis progression in untreated irish women with chronic hepatitis C contracted from immunoglobulin anti-D.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 4 10
(2009)
New drug technology produces marked improvement in hepatitis C therapy in animals
M. Persico, E. Persico, R. Suozzo, Salvatore Conte, Massimiliano Seta, L. Coppola, Bruno Palmentieri, F. Sasso, R. Torella (2000)
Natural history of hepatitis C virus carriers with persistently normal aminotransferase levels.Gastroenterology, 118 4
J. VandeBerg, S. Zola (2005)
A unique biomedical resource at riskNature, 437
Limin Chen, I. Borozan, J. Feld, Jing Sun, L. Tannis, C. Coltescu, J. Heathcote, A. Edwards, I. McGilvray (2005)
Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection.Gastroenterology, 128 5
J. Youn, Yu-Wen Hu, N. Tricoche, W. Pfahler, M. Shata, M. Dreux, F. Cosset, A. Folgori, Dong‐Hun Lee, B. Brotman, A. Prince (2008)
Evidence for Protection against Chronic Hepatitis C Virus Infection in Chimpanzees by Immunization with Replicating Recombinant Vaccinia VirusJournal of Virology, 82
Jarrod Bailey (2008)
An Assessment of the Role of Chimpanzees in AIDS Vaccine ResearchAlternatives to Laboratory Animals, 36
Catherine Bigger, K. Brasky, R. Lanford (2001)
DNA Microarray Analysis of Chimpanzee Liver during Acute Resolving Hepatitis C Virus InfectionJournal of Virology, 75
Eileen Foy, Kui Li, R. Sumpter, Y. Loo, C. Johnson, Chunfu Wang, P. Fish, M. Yoneyama, T. Fujita, S. Lemon, M. Gale (2005)
Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling.Proceedings of the National Academy of Sciences of the United States of America, 102 8
J. Bukh, X. Forns, S. Emerson, R. Purcell (2001)
Studies of Hepatitis C Virus in Chimpanzees and Their Importance for Vaccine DevelopmentIntervirology, 44
J. McHutchison, S. Gordon, E. Schiff, M. Shiffman, William Lee, V. Rustgi, Z. Goodman, M. Ling, S. Cort, J. Albrecht (1998)
Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.The New England journal of medicine, 339 21
M. Manns, J. McHutchison, S. Gordon, V. Rustgi, M. Shiffman, R. Reindollar, Z. Goodman, K. Koury, M. Ling, J. Albrecht (2001)
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trialThe Lancet, 358
M. Yanagi, R. Purcell, S. Emerson, J. Bukh (1999)
Hepatitis C virus: an infectious molecular clone of a second major genotype (2a) and lack of viability of intertypic 1a and 2a chimeras.Virology, 262 1
A Laurent, B. Krust, J. Galabru, J. Svab, A. Hovanessian, V. Lohmann, F. Körner, J. Koch, U. Herian, L. Theilmann, R. Bartenschlager (1999)
Replication of Subgenomic Hepatitis C Virus Rnas in a Hepatoma Cell Line
M. Berman, H. Alter, K. Ishak, R. Purcell, E. Jones (1979)
The chronic sequelae of non-A, non-B hepatitis.Annals of internal medicine, 91 1
J. Abraham, Nourrédine Himoudi, F. Kien, J. Berland, Audrey Codran, B. Bartosch, T. Baumert, G. Paranhos-Baccalà, C. Schuster, G. Inchauspe, M. Kieny (2004)
Comparative immunogenicity analysis of modified vaccinia Ankara vectors expressing native or modified forms of hepatitis C virus E1 and E2 glycoproteins.Vaccine, 22 29-30
T. Harada, D. Kim, K. Sagawa, Tetsuro Suzuki, Kazuaki Takahashi, I. Saito, Y. Matsuura, T. Miyamura (1995)
Characterization of an established human hepatoma cell line constitutively expressing non-structural proteins of hepatitis C virus by transfection of viral cDNA.The Journal of general virology, 76 ( Pt 5)
S. Lim, H. Soo, Y. Tan, S. Brenner, H. Horstmann, J. Mackenzie, M. Ng, S. Lim, W. Hong (2002)
Inducible system in human hepatoma cell lines for hepatitis C virus production.Virology, 303 1
Hua Tan, J. Derrick, Jin Hong, Corneliu Sanda, W. Grosse, H. Edenberg, Milton Taylor, S. Seiwert, L. Blatt (2005)
Global transcriptional profiling demonstrates the combination of type I and type II interferon enhances antiviral and immune responses at clinically relevant doses.Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, 25 10
D. Lau, B. Luxon, S. Xiao, M. Beard, S. Lemon (2005)
Intrahepatic gene expression profiles and alpha‐smooth muscle actin patterns in hepatitis C virus induced fibrosisHepatology, 42
N. Polakos, D. Drane, J. Cox, P. Ng, M. Selby, D. Chien, D. O’hagan, M. Houghton, X. Paliard (2001)
Characterization of Hepatitis C Virus Core-Specific Immune Responses Primed in Rhesus Macaques by a Nonclassical ISCOM VaccineThe Journal of Immunology, 166
J. Bukh, R. Engle, S. Govindarajan, R. Purcell (2008)
Immunity against the GBV‐B hepatitis virus in tamarins can prevent productive infection following rechallenge and is long‐livedJournal of Medical Virology, 80
(2009)
The Nucleoside Inhibitor MK-0608 Mediates Suppression of HCV Replication for >30 Days in Chronically Infected Chimpanzees
C. Chen, Yupeng He, L. Lu, H. Lim, R. Tripathi, T. Middleton, L. Hernandez, D. Beno, M. Long, W. Kati, Todd Bosse, D. Larson, R. Wagner, R. Lanford, W. Kohlbrenner, D. Kempf, T. Pilot-matias, A. Molla (2007)
Activity of a Potent Hepatitis C Virus Polymerase Inhibitor in the Chimpanzee ModelAntimicrobial Agents and Chemotherapy, 51
M. Heim, D. Moradpour, H. Blum (1999)
Expression of Hepatitis C Virus Proteins Inhibits Signal Transduction through the Jak-STAT PathwayJournal of Virology, 73
J. Dienstag, J. McHutchison (2006)
American Gastroenterological Association technical review on the management of hepatitis C.Gastroenterology, 130 1
D. Denton (2008)
Southwest Foundation of Biomedical Research
D. Woollard, G. Haqshenas, Xuebin Dong, Bridget Pratt, S. Kent, E. Gowans (2007)
Virus-Specific T-Cell Immunity Correlates with Control of GB Virus B Infection in MarmosetsJournal of Virology, 82
C. Rollier, E. Depla, J. Drexhage, E. Verschoor, B. Verstrepen, A. Fatmi, C. Brinster, A. Fournillier, J. Whelan, M. Whelan, D. Jacobs, G. Maertens, G. Inchauspe, J. Heeney (2004)
Control of Heterologous Hepatitis C Virus Infection in Chimpanzees Is Associated with the Quality of Vaccine-Induced Peripheral T-Helper Immune ResponseJournal of Virology, 78
M. Krawczyk, Malgorzata Wasowska-Lukawska, I. Oszczapowicz, A. Boguszewska‐Chachulska (2009)
Amidinoanthracyclines – a new group of potential anti-hepatitis C virus compounds, 390
S. Gehring, S. Gregory, N. Kuzushita, J. Wands (2005)
Type 1 interferon augments DNA‐based vaccination against hepatitis C virus core proteinJournal of Medical Virology, 75
Maria Smith, K. Walters, M. Korth, Matthew Fitzgibbon, S. Proll, Jill Thompson, M. Yeh, M. Shuhart, Jeff Furlong, P. Cox, David Thomas, J. Phillips, J. Kushner, N. Fausto, R. Carithers, M. Katze (2006)
Gene expression patterns that correlate with hepatitis C and early progression to fibrosis in liver transplant recipients.Gastroenterology, 130 1
J. Paeshuyse, A. Kaul, E. Clercq, B. Rosenwirth, J. Dumont, P. Scalfaro, R. Bartenschlager, J. Neyts (2006)
The non‐immunosuppressive cyclosporin DEBIO‐025 is a potent inhibitor of hepatitis C virus replication in vitroHepatology, 43
S. Sherlock (1988)
Treatment of hepatitis.The Journal of hospital infection, 11 Suppl A
Juliane Schmidt-Mende, E. Bieck, T. Hügle, F. Penin, C. Rice, H. Blum, D. Moradpour (2001)
Determinants for Membrane Association of the Hepatitis C Virus RNA-dependent RNA Polymerase*The Journal of Biological Chemistry, 276
Lixin Zhu, Jing Liu, Ye Ye, Youhua Xie, Y. Kong, Guang-di Li, Y. Wang (2004)
A candidate DNA vaccine elicits HCV specific humoral and cellular immune responses.World journal of gastroenterology, 10 17
Z. Qi, G. Kalkeri, J. Hanible, R. Prabhu, Frank Bastian, Robert Garry, S. Dash (2003)
Stem-loop structures II–IV of the 5′ untranslated sequences are required for the expression of the full-length hepatitis C virus genomeArchives of Virology, 148
M. Nascimbeni, E. Mizukoshi, M. Bosmann, M. Major, K. Mihalik, C. Rice, S. Feinstone, B. Rehermann (2003)
Kinetics of CD4+ and CD8+ Memory T-Cell Responses during Hepatitis C Virus Rechallenge of Previously Recovered ChimpanzeesJournal of Virology, 77
P. Maillard, K. Krawczyński, J. Nitkiewicz, C. Bronnert, M. Sidorkiewicz, P. Gounon, J. Dubuisson, G. Faure, R. Crainic, A. Budkowska (2001)
Nonenveloped Nucleocapsids of Hepatitis C Virus in the Serum of Infected PatientsJournal of Virology, 75
Kui Li, Eileen Foy, J. Ferreon, Mitsuyasu Nakamura, A. Ferreon, M. Ikeda, S. Ray, M. Gale, S. Lemon (2005)
Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF.Proceedings of the National Academy of Sciences of the United States of America, 102 8
R. Lanford, Catherine Bigger, Suzanne Bassett, G. Klimpel (2001)
The chimpanzee model of hepatitis C virus infections.ILAR journal, 42 2
(2009)
Safety Study of SPC3649 in Healthy Men
J. Bruijne, C. Weegink, Peter Jansen, H. Reesink (2009)
New developments in the antiviral treatment of hepatitis CVox Sanguinis, 97
S Ryder (2004)
Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy studyGut, 53
E. Jaeckel, M. Cornberg, H. Wedemeyer, T. Santantonio, J. Mayer, Myrga Zankel, Giuseppe Pastore, Manfred Dietrich, Christiane Trautwein, Michael Manns (2001)
Treatment of acute hepatitis C with interferon alfa-2b.The New England journal of medicine, 345 20
L. Seeff (2009)
The history of the “natural history” of hepatitis C (1968–2009)Liver International, 29
D. Kaplan, K. Sugimoto, K. Newton, Mary Valiga, F. Ikeda, A. Aytaman, F. Nunes, M. Lucey, B. Vance, R. Vonderheide, K. Reddy, J. McKeating, Kyong‐Mi Chang (2007)
Discordant role of CD4 T-cell response relative to neutralizing antibody and CD8 T-cell responses in acute hepatitis C.Gastroenterology, 132 2
C. Shepard, L. Finelli, M. Alter (2005)
Global epidemiology of hepatitis C virus infection.The Lancet. Infectious diseases, 5 9
R. Francesco, G. Migliaccio (2005)
Challenges and successes in developing new therapies for hepatitis CNature, 436
A. Kolykhalov, E. Agapov, K. Blight, K. Mihalik, S. Feinstone, C. Rice (1997)
Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA.Science, 277 5325
T. Poynard, P. Bedossa, P. Opolon, Metavir OBSVIRC (1997)
Natural history of liver fibrosis progression in patients with chronic hepatitis CThe Lancet, 349
S. Yagi, Ken-ichi Mori, E. Tanaka, A. Matsumoto, Fumiko Sunaga, K. Kiyosawa, K. Yamaguchi (2005)
Identification of novel HCV subgenome replicating persistently in chronic active hepatitis C patientsJournal of Medical Virology, 77
Government Printing Office
R. Prabhu, V. Joshi, R. Garry, F. Bastian, S. Haque, F. Regenstein, S. Thung, S. Dash (2004)
Interferon alpha-2b inhibits negative-strand RNA and protein expression from full-length HCV1a infectious clone.Experimental and molecular pathology, 76 3
D. Moradpour, T. Wakita, J. Wands, H. Blum (1998)
Tightly regulated expression of the entire hepatitis C virus structural region in continuous human cell lines.Biochemical and biophysical research communications, 246 3
A. Franzusoff, R. Duke, T. King, Yingnian Lu, T. Rodell (2005)
Yeasts encoding tumour antigens in cancer immunotherapyExpert Opinion on Biological Therapy, 5
S. Capone, Immacolata Zampaglione, A. Vitelli, M. Pezzanera, L. Kierstead, Janine Burns, L. Ruggeri, Mirko Arcuri, M. Cappelletti, A. Meola, B. Ercole, R. Tafi, C. Santini, A. Luzzago, T. Fu, S. Colloca, G. Ciliberto, R. Cortese, A. Nicosia, E. Fattori, A. Folgori (2006)
Modulation of the Immune Response Induced by Gene Electrotransfer of a Hepatitis C Virus DNA Vaccine in Nonhuman PrimatesThe Journal of Immunology, 177
Edoardo Cervoni (1998)
Hepatitis CThe Lancet, 351
M. Manns, G. Foster, J. Rockstroh, S. Zeuzem, F. Zoulim, M. Houghton (2008)
The way forward in HCV treatment — finding the right pathNature Reviews Drug Discovery, 7
Joseph Kim, K. Morgenstern, Chao Lin, T. Fox, Maureen Dwyer, J. Landro, S. Chambers, W. Markland, C. Lepre, E. O'malley, S. Harbeson, C. Rice, M. Murcko, P. Caron, J. Thomson (1996)
Crystal Structure of the Hepatitis C Virus NS3 Protease Domain Complexed with a Synthetic NS4A Cofactor PeptideCell, 87
H. Alter, M. Houghton (2000)
Clinical Medical Research Award. Hepatitis C virus and eliminating post-transfusion hepatitis.Nature medicine, 6 10
E. Tabor, J. Drucker, J. Hoofnagle, M. April, R. Gerety, L. Seeff, D. Jackson, L. Barker, G. Pineda‐Tamondong (1978)
TRANSMISSION OF NON-A, NON-B HEPATITIS FROM MAN TO CHIMPANZEEThe Lancet, 311
A. Sakai, M. Claire, K. Faulk, S. Govindarajan, S. Emerson, R. Purcell, J. Bukh (2003)
The p7 polypeptide of hepatitis C virus is critical for infectivity and contains functionally important genotype-specific sequencesProceedings of the National Academy of Sciences of the United States of America, 100
K. Neukam, J. Macías, J. Mira, J. Pineda (2009)
A review of current anti-HCV treatment regimens and possible future strategiesExpert Opinion on Pharmacotherapy, 10
Office (2007)
M. Koziel, D. Dudley, N. Afdhal, Q. Choo, M. Houghton, R. Ralston, B. Walker (1993)
Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCVJournal of Virology, 67
(1991)
Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: comparison with reported isolates for conserved and divergent regions.
P. Vermij (2003)
Europe's last research chimps to retireNature Medicine, 9
M. Makimura, S. Miyake, N. Akino, K. Takamori, Y. Matsuura, T. Miyamura, I. Saito (1996)
Induction of antibodies against structural proteins of hepatitis C virus in mice using recombinant adenovirus.Vaccine, 14 1
Y. Hirata, M. Sudoh, M. Kohara (2008)
[Suppression of hepatitis C virus with the reagent targetting host factors].Uirusu, 58 2
V. Soriano, A. Madejón, E. Vispo, P. Labarga, J. García-Samaniego, L. Martín-Carbonero, J. Sheldon, M. Bottecchia, P. Tuma, P. Barreiro (2008)
Emerging drugs for hepatitis CExpert Opinion on Emerging Drugs, 13
Jon Cohen (2007)
The Endangered Lab ChimpScience, 315
S. Boccato, R. Pistis, F. Noventa, M. Guido, L. Benvegnu', A. Alberti (2006)
Fibrosis progression in initially mild chronic hepatitis CJournal of Viral Hepatitis, 13
U. Sauer (2000)
[Reasons for not using primates in research].ALTEX, 17 4
F. Stevenson, W. Rosenberg (2001)
DNA vaccination: a potential weapon against infection and cancerVox Sanguinis, 80
K. Mullis, F. Faloona (1987)
Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction.Methods in enzymology, 155
D. Lamarre, P. Anderson, M. Bailey, P. Beaulieu, G. Bolger, P. Bonneau, M. Bös, D. Cameron, M. Cartier, M. Cordingley, A. Faucher, N. Goudreau, S. Kawai, G. Kukolj, L. Lagacé, S. LaPlante, H. Narjes, M. Poupart, J. Rancourt, R. Sentjens, R. George, B. Simoneau, G. Steinmann, D. Thibeault, Y. Tsantrizos, S. Weldon, C. Yong, M. Llinàs-Brunet (2003)
An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virusNature, 426
The USA is the only significant user of chimpanzees in biomedical research in the world, since many countries have banned or limited the practice due to substantial ethical, economic and scientific concerns. Advocates of chimpanzee use cite hepatitis C research as a major reason for its necessity and continuation, in spite of supporting evidence that is scant and often anecdotal. This paper examines the scientific and ethical issues surrounding chimpanzee hepatitis C research, and concludes that claims of the necessity of chimpanzees in historical and future hepatitis C research are exaggerated and unjustifiable, respectively. The chimpanzee model has several major scientific, ethical, economic and practical caveats. It has made a relatively negligible contribution to knowledge of, and tangible progress against, the hepatitis C virus compared to non-chimpanzee research, and must be considered scientifically redundant, given the array of alternative methods of inquiry now available. The continuation of chimpanzee use in hepatitis C research adversely affects scientific progress, as well as chimpanzees and humans in need of treatment. Unfounded claims of its necessity should not discourage changes in public policy regarding the use of chimpanzees in US laboratories.
Alternatives to Laboratory Animals – SAGE
Published: Oct 1, 2010
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.